Carolyn J. Henry

Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision

Cheryl A. London, Phyllis B. Malpas, Stacey L. Wood-Follis et al. · Clinical Cancer Research · 2009 · 416 citations · Full text

Preliminary evidence for biologic activity of toceranib phosphate (Palladia^®) in solid tumours

Cheryl A. London, Tamra Mathie, N. Stingle et al. · Veterinary and Comparative Oncology · 2011 · 229 citations

Surgical Oncology, Pathology, Veterinary Research +17

Amputation and Carboplatin for Treatment of Dogs With Osteosarcoma: 48 Cases (1991 to 1993)

Philip J. Bergman, E. Gregory MacEwen, Ilene D. Kurzman et al. · Journal of Veterinary Internal Medicine · 1996 · 225 citations

Veterinary Surgery, Veterinary Pathology, Veterinary Science +12

A population study of neutering status as a risk factor for canine prostate cancer

Jeffrey N. Bryan, Matthew R. Keeler, Carolyn J. Henry et al. · The Prostate · 2007 · 175 citations

Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma.

Carolyn J. Henry, Dudley L. McCaw, Susan E. Turnquist et al. · PubMed · 2003 · 145 citations